Conditions · Pancreatic cancer
Pancreatic cancer — frontier options in Ohio
Prefer to look first? Browse the live map without signing up.
30 open options
- TRIALNARECRUITING
A Study Evaluating a New Radiation Treatment Workflow (NGDS)
Next Generation Delivery System (NGDS) — 2 sites
- TRIALPHASE1RECRUITING
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
LY4052031 — 39 sites
- TRIALNARECRUITING
Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study
Chemical Ablation · Computed Tomography · Electronic Health Record Review — 1 site
- TRIALPHASE1 / PHASE2RECRUITING
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
64Cu-LNTH-1363S — 5 sites
- TRIALPHASE2 / PHASE3RECRUITING
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
SBP-101 · Nab-paclitaxel · Gemcitabine — 93 sites
- TRIALPHASE2 / PHASE3RECRUITING
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Zanzalintinib · Everolimus — 131 sites
- TRIALPHASE1 / PHASE2NOT_YET_RECRUITING
DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer
Biospecimen Collection · Computed Tomography · Dynamic Contrast-Enhanced Magnetic Resonance Imaging — 1 site
- TRIALPHASE1RECRUITING
Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain
Simulation-free workflow · Celiac plexus SBRT — 1 site
- TRIALPHASE1 / PHASE2RECRUITING
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
JAB-23E73 · JAB-23E73 · JAB-23E73 — 4 sites
- TRIALPHASE2RECRUITING
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Biospecimen Collection · Computed Tomography · Magnetic Resonance Imaging — 454 sites
- TRIALPHASE3RECRUITING
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
19 French Blake Drain — 1 site
- TRIALNARECRUITING
MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer
Electronic Health Record Review · Smartphone Application-based Intervention · Survey Administration — 1 site
- TRIALPHASE1 / PHASE2RECRUITING
Lead-212 PSV359 Therapy for Patients With Solid Tumors
[203Pb]Pb-PSV359 · [212Pb]Pb-PSV359 — 11 sites
- TRIALPHASE1RECRUITING
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
XL309 · Olaparib — 16 sites
- TRIALPHASE3RECRUITING
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Glufosfamide · Fluorouracil — 3 sites
- TRIALPHASE1 / PHASE2RECRUITING
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
MT-4561 — 6 sites
- TRIALPHASE1RECRUITING
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
CX-5461 — 8 sites
- TRIALPHASE3RECRUITING
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Atebimetinib · GnP · mGnP — 51 sites
- TRIALNANOT_YET_RECRUITING
Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplasms
Clinical Intervention or Procedure · Electronic Health Record Review · Endoscopic Ultrasound-Guided Fine-Needle Aspiration of the Pancreas — 1 site
- TRIALPHASE1RECRUITING
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
BCA101 · Pembrolizumab — 20 sites
- TRIALPHASE2RECRUITING
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Capecitabine · Temozolomide — 448 sites
- TRIALPHASE2RECRUITING
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Pemigatinib · Computed Tomography (CT) · Magnetic Resonance Imaging — 109 sites
- TRIALPHASE1 / PHASE2RECRUITING
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RMC-6236 — 21 sites
- TRIALPHASE1RECRUITING
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
LY3962673 · Cetuximab · Gemcitabine — 52 sites
- TRIALPHASE1RECRUITING
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
ASP5834 · panitumumab — 20 sites
- TRIALPHASE1 / PHASE2RECRUITING
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
ART0380 · Gemcitabine · Irinotecan — 82 sites
- TRIALPHASE3RECRUITING
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Biopsy Procedure · Biospecimen Collection · Capecitabine — 333 sites
- TRIALPHASE1RECRUITING
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Biopsy Procedure · Biospecimen Collection · Computed Tomography — 18 sites
- TRIALNARECRUITING
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
Daily Adaptive External Beam Radiation Therapy — 4 sites
- TRIALPHASE3RECRUITING
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
[18F]FAPI-74 PET/CT — 16 sites
Live from ClinicalTrials.gov, refreshed at most hourly · registry query ↗
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.